• Publications
  • Influence
Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone.
BACKGROUND Patients surviving ventricular fibrillation (VF) or sustained ventricular tachycardia (VT) are at a high risk of death due to a recurrence of arrhythmia. The implantable cardioverterExpand
  • 1,461
  • 58
  • PDF
Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial.
BACKGROUND AND METHODS In the Cardiac Arrhythmia Suppression Trial, designed to test the hypothesis that suppression of ventricular ectopy after a myocardial infarction reduces the incidence ofExpand
  • 2,675
  • 53
Relationships Between Sinus Rhythm, Treatment, and Survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study
Background—The AFFIRM Study showed that treatment of patients with atrial fibrillation and a high risk for stroke or death with a rhythm-control strategy offered no survival advantage over aExpand
  • 1,100
  • 24
  • PDF
Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control.
The Canadian Cardiovascular Society (CCS) published the complete set of 2010 Atrial Fibrillation (AF) Guidelines in the January, 2011 issue of the Canadian Journal of Cardiology. During itsExpand
  • 491
  • 20
  • PDF
Noninvasive risk assessment early after a myocardial infarction the REFINE study.
OBJECTIVES This study sought to determine whether combined assessment of autonomic tone plus cardiac electrical substrate identifies most patients at risk of serious events after myocardialExpand
  • 313
  • 15
Prophylactic Oral Amiodarone for the Prevention of Arrhythmias that Begin Early After Revascularization, Valve Replacement, or Repair: PAPABEAR: a randomized controlled trial.
CONTEXT Atrial tachyarrhythmias after cardiac surgery are associated with adverse outcomes and increased costs. Previous trials of amiodarone prophylaxis, while promising, were relatively small andExpand
  • 259
  • 10
  • PDF
2014 focused update of the Canadian Cardiovascular Society Guidelines for the management of atrial fibrillation.
Atrial fibrillation (AF) is an extremely common clinical problem with an important population morbidity and mortality burden. The management of AF is complex and fraught with many uncertain andExpand
  • 370
  • 9
Assessment of the cardiac patient for fitness to drive: drive subgroup executive summary.
  • 68
  • 9
Survival After Coronary Revascularization Among Patients With Kidney Disease
Background—The optimal approach to revascularization in patients with kidney disease has not been determined. We studied survival by treatment group (CABG, percutaneous coronary intervention [PCI],Expand
  • 227
  • 8
Sudden death in patients with implantable cardioverter defibrillators: the importance of post-shock electromechanical dissociation.
OBJECTIVES The purpose of this study was to determine the mechanisms of sudden death (SD) in patients with ventricular tachyarrhythmias (ventricular tachycardia/ventricular fibrillation [VT/VF])Expand
  • 214
  • 7
  • PDF